---
name: BioAscent Discovery
slug: bioascent-discovery
site: cro
website_domain: bioascent.com
summary: BioAscent is an integrated drug discovery CRO offering medicinal and synthetic chemistry, computational chemistry, biochemical and biophysical assay development, high-throughput screening, DMPK, flow cytometry, and compound management services to biotech and pharma clients globally. Headquartered in Newhouse, United Kingdom.
tagline: Integrated drug discovery: chemistry, biosciences, DMPK, and computational expertise.
founded_year: 2013
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: UK
tier2_domain_verified: false
updated_at: 2026-10-07T07:00:55.788Z
services_count: 8
modalities_count: 0
indications_count: 2
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# BioAscent Discovery

Integrated drug discovery: chemistry, biosciences, DMPK, and computational expertise.

Listed on cro.directory.

## Summary

BioAscent is an integrated drug discovery CRO offering medicinal and synthetic chemistry, computational chemistry, biochemical and biophysical assay development, high-throughput screening, DMPK, flow cytometry, and compound management services to biotech and pharma clients globally. Headquartered in Newhouse, United Kingdom.

## At a glance

- Founded: 2013
- HQ country: UK

## Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Flow Cytometry Services

## Indications

- Neurology
- Immunology

## Locations

- Headquarters, Newhouse, Scotland, UK

## Long description

## Overview

BioAscent Discovery is a leading provider of integrated drug discovery services founded in 2013 and based at the former Organon/MSD R&D site in Newhouse, Scotland, UK. The company serves clients ranging from small virtual biotechs to large established pharmaceutical companies.

## Core Capabilities

**Chemistry & Computational Services**
- Medicinal chemistry and synthetic chemistry
- Computational chemistry and in silico discovery (launched 2021; experienced 27% revenue growth)
- Physicochemical profiling and DMPK
- Compound management, logistics, and shipping
- Access to in-house diversity, fragment, and chemogenomic libraries
- External library selection and sourcing

**Biology & Assay Development**
- De novo assay development
- Biochemical, biophysical, and cellular assay development
- Target analysis and bespoke screening strategies
- Compound screening including high-throughput screening (HTS)
- Flow cytometry (newly enhanced with NovoCyte 3000 Agilent instrument, installed February 2025)
- Immune profiling, cell cycle analysis, and target validation
- Multi-parameter cell analysis with up to 17 parameters

**Protein Science**
- Protein production
- Surface plasmon resonance (SPR) and biophysics
- Structural biology

**Specialized Focus Areas**
- Mitochondrial biology
- GPCR drug discovery
- CNS drug discovery
- AI and machine learning applications in drug design

## Differentiation

BioAscent emphasizes science-led, integrated discovery with close collaboration between chemistry, biosciences, and computational teams to accelerate timelines, reduce costs, and improve success likelihood. The company maintains in-house compound libraries and recently expanded capabilities with advanced flow cytometry instrumentation.

## Related companies

- [Beantown Biotech](/companies/beantownbiotech) (Discovery Research, Target Identification & Validation) — [Compare](/compare/beantownbiotech/bioascent-discovery)
- [Axxam](/companies/axxam) (Discovery Research, Target Identification & Validation) — [Compare](/compare/axxam/bioascent-discovery)
- [Eurofins Discovery](/companies/eurofinsdiscovery) (Discovery Research, Target Identification & Validation) — [Compare](/compare/bioascent-discovery/eurofinsdiscovery)
- [TRiCBIO](/companies/tricbio) (Discovery Research, Target Identification & Validation) — [Compare](/compare/bioascent-discovery/tricbio)
- [PozeSCAF Inc.](/companies/pozescaf-discovery-solutions) (Discovery Research, Target Identification & Validation) — [Compare](/compare/bioascent-discovery/pozescaf-discovery-solutions)
- [Aurigene Pharmaceutical Services Limited](/companies/aurigeneservices) (Discovery Research, Target Identification & Validation) — [Compare](/compare/aurigeneservices/bioascent-discovery)
- [ChemDiv](/companies/chemdiv) (Discovery Research, Target Identification & Validation) — [Compare](/compare/bioascent-discovery/chemdiv)
- [AAPharmaSyn](/companies/aapharmasyn) (Discovery Research, Medicinal Chemistry) — [Compare](/compare/aapharmasyn/bioascent-discovery)

_Profile last updated: 2026-10-07T07:00:55.788Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.